ETCAMAH
NDC 0310-0075, camizestrant, tablet, film coated, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-0075
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220359
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0075 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CAMIZESTRANT75 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-0075-01 | 00310007501 | 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-0075-01) |
| 0310-0075-95 | 00310007595 | 7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-0075-95) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c54223d3-f3c7-4186-afa0-429d84805826
Use it
Look up 0310-0075 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0075 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-0075. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.